CTD Holdings Initiates Research Program to Explore Cyclodextrin Therapy for Alzheimer's Disease
ALACHUA, FL--(Marketwired - January 29, 2018) - CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announced today that the company has …